BackPiramal Pharma Limited Overview

Piramal Pharma Limited Intangible Assets

Latest intangible assets for PPLPHARMA.BO: $32B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$31.54B
↑ 5.71% YoYΔ $1.70B vs prior year quarter

Peer trimmed avg / median

Loading

Piramal Pharma Limited Intangible Assets History

Loading

Piramal Pharma Limited vs. peers: Intangible Assets Comparison

Loading

Piramal Pharma Limited Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Piramal Pharma Limited (PPLPHARMA.BO) FAQ

Piramal Pharma Limited posts a intangible assets of $32B as of September 2026. That compares with $30B in the prior-year period — up 5.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Piramal Pharma Limited's intangible assets was $30B. The latest reading is $32B — a 5.7% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of Piramal Pharma Limited's financial statement story. At $32B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PPLPHARMA.BO's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Piramal Pharma Limited's other metric pages and overview cover the third.